B. Marini

发表

Risk factors and impact of Clostridium difficile recurrence on haematology patients

D. Bixby, Gianni B. Scappaticci, Anthony J. Perissinotti, 2017, The Journal of antimicrobial chemotherapy.

Molecular profiling and targeted therapy in pediatric gliomas: review and consensus recommendations.

R. Beroukhim, K. Ligon, S. Mueller, 2019, Neuro-oncology.

Clinical considerations for the use of FLT3 inhibitors in acute myeloid leukemia.

D. Bixby, Anthony J. Perissinotti, B. Marini, 2019, Critical reviews in oncology/hematology.

Late-onset complications with bendamustine versus CHOP or CVP based chemoimmunotherapy in indolent Non-Hodgkin’s lymphoma

T. Phillips, Anthony J. Perissinotti, B. Marini, 2021, Leukemia & lymphoma.

A review of CD19-targeted immunotherapies for relapsed or refractory acute lymphoblastic leukemia

Anthony J. Perissinotti, B. Marini, R. K. DasGupta, 2018, Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners.

Real-Life Challenges to the Use of Antifungal Agents in Hematology Patients

Anthony J. Perissinotti, B. Marini, 2017, Current Fungal Infection Reports.

Impact of high dose cytarabine dosing strategies in obese patients with acute myeloid leukemia.

Patrick W. Burke, D. Bixby, Anthony J. Perissinotti, 2021, Leukemia research.

Predictors for requiring re-induction chemotherapy in acute myeloid leukemia patients with residual disease on day 14 bone marrow assessment.

D. Bixby, Gianni B. Scappaticci, Anthony J. Perissinotti, 2017, Leukemia research.

Utility of methicillin‐resistant Staphylococcus aureus (MRSA) nasal screening in patients with acute myeloid leukemia (AML)

Patrick W. Burke, D. Bixby, Gianni B. Scappaticci, 2021, Transplant infectious disease : an official journal of the Transplantation Society.

Successful reintroduction of blinatumomab in a patient with relapsed/refractory acute lymphoblastic leukemia following grade 4 cytokine release syndrome

Patrick W. Burke, Anthony J. Perissinotti, B. Marini, 2018, Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners.

Characterizing and targeting PDGFRA alterations in pediatric high-grade glioma

Chris Jones, D. Robinson, P. Robertson, 2016, Oncotarget.

Evaluating the Role of Novel Oncology Agents: Oncology Stewardship in Relapsed/Refractory Diffuse Large B-Cell Lymphoma.

T. Phillips, Anthony J. Perissinotti, B. Marini, 2020, Clinical lymphoma, myeloma & leukemia.

Oncology stewardship in acute myeloid leukemia

D. Bixby, Anthony J. Perissinotti, B. Marini, 2022, Annals of Hematology.

Multicenter comparison of high-dose cytarabine-based regimens versus liposomal daunorubicin and cytarabine (CPX-351) in patients with secondary acute myeloid leukemia

T. Kadia, D. Bixby, Anthony J. Perissinotti, 2021, Leukemia & lymphoma.

with Chronic Rejection Allograft Acceptance and Fibrosis Associated Signaling and IL-17 in b Role of T Cell TGF

Y. Iwakura, S. Faust, D. Gordon, 2009 .

Identification of variant APL translocations PRKAR1A-RARα and ZBTB16-RARα (PLZF-RARα) through the MI-ONCOSEQ platform.

D. Robinson, D. Bixby, Anthony J. Perissinotti, 2021, Cancer genetics.

Real world use of FLT3 inhibitors for treatment of FLT3+ acute myeloid leukemia (AML): A single center, propensity-score matched, retrospective cohort study

D. Bixby, Anthony J. Perissinotti, B. Marini, 2021, Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners.

Expanding the armamentarium for chronic lymphocytic leukemia: A review of novel agents in the management of chronic lymphocytic leukemia

Anthony J. Perissinotti, B. Marini, L. Samanas, 2017, Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners.

Oncology stewardship in acute myeloid leukemia

D. Bixby, Anthony J. Perissinotti, B. Marini, 2022, Annals of Hematology.

Hard-wired biases in trials: maintenance azacitidine in patients with acute myeloid leukemia and framework for future trials

T. Olivier, B. Marini, V. Prasad, 2022, Blood advances.

Impact of prophylactic intrathecal chemotherapy on CNS relapse rates in AML patients presenting with hyperleukocytosis

D. Bixby, Anthony J. Perissinotti, B. Marini, 2019, Leukemia & lymphoma.

Real world outcomes in patients with Philadelphia chromosome positive acute lymphoblastic leukemia undergoing allogeneic stem cell transplantation–A single institution experience

Radhika Takiar, D. Bixby, Anthony J. Perissinotti, 2022, Leukemia research reports.

The FOSSIL Study: FLAG or standard 7+3 induction therapy in secondary acute myeloid leukemia.

M. Talpaz, I. Maillard, D. Bixby, 2018, Leukemia research.

Impact of a vincristine dose cap on the incidence of neuropathies with DA-EPOCH-R for the treatment of aggressive lymphomas

M. Kaminski, T. Phillips, Anthony J. Perissinotti, 2019, Leukemia & lymphoma.

Maintenance sorafenib in FLT3-ITD AML following allogeneic HCT favorably impacts relapse and overall survival

T. Braun, S. Choi, J. Magenau, 2019, Bone Marrow Transplantation.

Comparative pharmacokinetic analysis of the blood-brain barrier penetration of dasatinib and ponatinib in mice

K. Ravi, D. Bixby, Anthony J. Perissinotti, 2021, Leukemia & lymphoma.

Early Antibiotic Discontinuation or De-escalation in High-Risk Patients With AML With Febrile Neutropenia and Prolonged Neutropenia.

D. Bixby, Anthony J. Perissinotti, J. Nagel, 2022, Journal of the National Comprehensive Cancer Network : JNCCN.

PET-guided, BEACOPPescalated therapy in advanced Hodgkin lymphoma.

Anthony J. Perissinotti, B. Marini, Victoria R. Nachar, 2019, The Lancet. Oncology.

Risk factors for subtherapeutic levels of posaconazole tablet

C. Berglund, Anthony J. Perissinotti, J. Nagel, 2017, The Journal of antimicrobial chemotherapy.

PEGging down risk factors for peg-asparaginase hepatotoxicity in patients with acute lymphoblastic leukemia†

D. Bixby, Anthony J. Perissinotti, B. Marini, 2018, Leukemia & lymphoma.

Impact of antibacterial prophylaxis during reinduction chemotherapy for relapse/refractory acute myeloid leukemia

D. Bixby, Anthony J. Perissinotti, J. Nagel, 2017, Supportive Care in Cancer.

Risk factors for recurrent Clostridium difficile infection in hematopoietic stem cell transplant recipients

D. Aronoff, J. Nagel, B. Marini, 2014, Transplant infectious disease : an official journal of the Transplantation Society.

Optimal sequence of daratumumab and elotuzumab in relapsed and refractory multiple myeloma

Anthony J. Perissinotti, B. Marini, Anna M. Brown, 2019, Leukemia & lymphoma.

Clinical Availability of ATRA for Patients With Suspected Acute Promyelocytic Leukemia: Why Guidelines May Not Be Followed.

D. Bixby, Anthony J. Perissinotti, B. Marini, 2021, Journal of the National Comprehensive Cancer Network : JNCCN.

Hybrid chemotherapy regimen (FLAG-IDA-vincristine-prednisone) for acute leukemia with mixed-phenotype blasts.

D. Bixby, Anthony J. Perissinotti, B. Marini, 2021, Leukemia research.

Incidence and Risk Factors for Breakthrough Invasive Mold Infections in Acute Myeloid Leukemia Patients Receiving Remission Induction Chemotherapy

D. Bixby, Anthony J. Perissinotti, B. Marini, 2019, Open forum infectious diseases.

Outcomes of previously untreated elderly patients with AML: a propensity score-matched comparison of clofarabine vs. FLAG

M. Talpaz, D. Bixby, Anthony J. Perissinotti, 2018, Annals of Hematology.

Risk for Invasive Fungal Infections during Acute Myeloid Leukemia Induction Therapy: a True Association with Echinocandins?

Anthony J. Perissinotti, B. Marini, D. Kaul, 2014, Antimicrobial Agents and Chemotherapy.

Everolimus improves the efficacy of dasatinib in PDGFRα-driven glioma.

A. Chinnaiyan, J. Sarkaria, P. Robertson, 2020, The Journal of clinical investigation.

Targeting and Therapeutic Monitoring of H3K27M-Mutant Glioma

K. Ravi, B. Marini, Amy K. Bruzek, 2020, Current Oncology Reports.

Solving coagulation conundrums: comparing prophylaxis strategies in adult patients receiving PEG-asparaginase

J. Auten, D. Bixby, Anthony J. Perissinotti, 2022, Leukemia & lymphoma.

Blood-brain barrier-adapted precision medicine therapy for pediatric brain tumors.

A. Chinnaiyan, Xuhong Cao, K. Kasaian, 2017, Translational research : the journal of laboratory and clinical medicine.

Rational use of rasburicase for the treatment and management of tumor lysis syndrome

Anthony J. Perissinotti, B. Marini, S. Shaikh, 2018, Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners.

Everolimus improves the efficacy of dasatinib in the treatment of PDGFRA-driven glioma

Brendan, P. Robertson, C. Kumar-Sinha, 2019 .

Clinically Integrated Sequencing Alters Therapy in Children and Young Adults With High-Risk Glial Brain Tumors.

A. Chinnaiyan, Xuhong Cao, K. Kasaian, 2018, JCO precision oncology.

Identification and targeting of an FGFR fusion in a pediatric thalamic â€œcentral oligodendrogliomaâ€•

P. Robertson, K. McFadden, B. Marini, 2018 .

Contemporary treatment options for a classical disease: Advanced Hodgkin lymphoma.

Anthony J. Perissinotti, B. Marini, Anna M. Brown, 2020, Critical reviews in oncology/hematology.

Catalyzing improvements in ALL therapy with asparaginase.

D. Bixby, Anthony J. Perissinotti, B. Marini, 2017, Blood reviews.

Novel approaches in the pharmacotherapy of skeletal-related events in metastatic castrate-resistant prostate cancer.

W. Figg, S. Spencer, B. Marini, 2012, Anticancer research.

Asparaginase activity levels and monitoring in patients with acute lymphoblastic leukemia

B. Bostrom, Y. Messinger, Anthony J. Perissinotti, 2018, Leukemia & lymphoma.

Pegasparaginase silent inactivation during therapy for NK/T cell lymphoma

T. Phillips, Anthony J. Perissinotti, B. Marini, 2018, Leukemia & lymphoma.

Role of T Cell TGFβ Signaling and IL-17 in Allograft Acceptance and Fibrosis Associated with Chronic Rejection1

Y. Iwakura, S. Faust, W. Zou, 2009, The Journal of Immunology.

with Chronic Rejection Allograft Acceptance and Fibrosis Associated Signaling and IL-17 in b Role of T Cell TGF

Zou, Y. Iwakura, S. Faust, 2009 .

Lenalidomide Plus Hypomethylating Agent as a Treatment Option in Acute Myeloid Leukemia With Recurrent Genetic Abnormalities-AML With inv(3)(q21.3q26.2) or t(3;3)(q21.3;q26.2); GATA2, MECOM.

H. Erba, D. Bixby, Anthony J. Perissinotti, 2019, Clinical lymphoma, myeloma & leukemia.

Identification and targeting of an FGFR fusion in a pediatric thalamic “central oligodendroglioma”

P. Robertson, K. McFadden, B. Marini, 2017, npj Precision Oncology.

Successful use of cytarabine and bendamustine in a patient with mantle cell lymphoma and acute renal failure using intermittent hemodialysis: A case report

Matthew D Ettleson, T. Phillips, K. Bongers, 2019, Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners.

The leukemia strikes back: a review of pathogenesis and treatment of secondary AML

D. Bixby, Anthony J. Perissinotti, B. Marini, 2019, Annals of Hematology.

Minimizing waste during preparation of blinatumomab infusions.

D. Bixby, Anthony J. Perissinotti, B. Marini, 2016, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.

Risk of graft-versus-host disease with rituximab-containing conditioning regimens in allogeneic hematopoietic stem cell transplant

B. Marini, D. Frame, D. Markstrom, 2017, Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners.

Treatment of dyslipidemia in allogeneic hematopoietic stem cell transplant patients.

S. Choi, B. Marini, D. Frame, 2015, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Successful use of high-dose cytarabine in a patient with acute myeloid leukemia and severe hepatic dysfunction

D. Bixby, Anthony J. Perissinotti, B. Marini, 2016, Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners.

Role of caplacizumab in the treatment of acquired thrombotic thrombocytopenic purpura

Anthony J. Perissinotti, B. Marini, R. Khoriaty, 2020, Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners.

Impact of number of lumens in central-venous catheters on central-line bloodstream infection (CLABSI) and venous thromboembolism (VTE) risk in patients with acute leukemia

D. Bixby, Anthony J. Perissinotti, B. Marini, 2021, Infection Control & Hospital Epidemiology.

Efficacy of HMA +/- Venetoclax or Intensive Chemotherapy in Blast-Phase Myeloproliferative Neoplasms

M. Talpaz, D. Bixby, Anthony J. Perissinotti, 2021, Blood.

Propensity-score Matched Comparison of Salvage Chemotherapy Regimens in Relapsed/Refractory Acute Myeloid Leukemia.

D. Bixby, Anthony J. Perissinotti, B. Marini, 2021, Clinical lymphoma, myeloma & leukemia.

Panobinostat penetrates the blood–brain barrier and achieves effective brain concentrations in a murine model

B. Marini, C. Koschmann, Miao He, 2021, Cancer Chemotherapy and Pharmacology.

Multicenter comparison of first salvage chemotherapy versus novel therapy regimens in adult relapsed/refractory acute lymphoblastic leukemia

D. Bixby, Anthony J. Perissinotti, B. Marini, 2022, Leukemia & lymphoma.

Successful use of blinatumomab in a patient with acute lymphoblastic leukemia and severe hepatic dysfunction

Anthony J. Perissinotti, B. Marini, K. Pettit, 2020, Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners.

Daptomycin nonsusceptible vancomycin resistant Enterococcus bloodstream infections in patients with hematological malignancies: risk factors and outcomes

C. Kauffman, Anthony J. Perissinotti, B. Marini, 2017, Leukemia & lymphoma.

Risk factors for piperacillin/tazobactam-resistant Gram-negative infection in hematology/oncology patients with febrile neutropenia

J. Nagel, B. Marini, K. Gregg, 2015, Supportive Care in Cancer.

CTNI-35. PHASE 0/1 TRIAL OF MYCOPHENOLATE MOFETIL COMBINED WITH CHEMORADIATION TO OVERCOME TREATMENT RESISTANCE IN NEWLY DIAGNOSED AND RECURRENT GLIOBLASTOMA BY TARGETING PURINE METABOLISM

Yilun Sun, M. Schipper, L. Junck, 2022, Neuro-Oncology.

A single-center multidisciplinary approach to managing the global Erwinia asparaginase shortage

R. Hutchinson, D. Bixby, Anthony J. Perissinotti, 2019, Leukemia & lymphoma.

Pharmacokinetic and clinical considerations for monitoring asparaginase activity levels during pegaspargase therapy

Anthony J. Perissinotti, B. Marini, Maressa Santarossa, 2015, Pediatric blood & cancer.

COVID-19 infection outcomes in patients receiving CD20 targeting T-cell engaging bispecific antibodies for B-cell non-Hodgkin lymphoma

T. Phillips, Anthony J. Perissinotti, B. Marini, 2023, Annals of Hematology.